Reported Earnings • May 15
First quarter 2026 earnings released: EPS: US$0.15 (vs US$0.043 in 1Q 2025) First quarter 2026 results: EPS: US$0.15 (up from US$0.043 in 1Q 2025). Revenue: US$11.5m (flat on 1Q 2025). Net income: US$2.62m (up 402% from 1Q 2025). Profit margin: 23% (up from 4.5% in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 24% per year whereas the company’s share price has fallen by 25% per year. Announcement • Apr 27
Presurance Holdings, Inc., Annual General Meeting, Jun 03, 2026 Presurance Holdings, Inc., Annual General Meeting, Jun 03, 2026. Recent Insider Transactions • Apr 07
President & CEO recently bought US$72k worth of stock On the 1st of April, Brian Roney bought around 100k shares on-market at roughly US$0.72 per share. This transaction amounted to 24% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Brian's only on-market trade for the last 12 months. Reported Earnings • Mar 30
Full year 2025 earnings released: US$1.51 loss per share (vs US$2.87 loss in FY 2024) Full year 2025 results: US$1.51 loss per share (improved from US$2.87 loss in FY 2024). Revenue: US$37.1m (down 44% from FY 2024). Net loss: US$18.4m (loss narrowed 47% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 35% per year whereas the company’s share price has fallen by 30% per year. Announcement • Mar 07
Presurance Holdings, Inc. Receives Notice of Non-Compliance with Nasdaq Minimum Bid Price and Potential Delisting On March 3, 2026, Presurance Holdings, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that because the closing bid price of the Company’s common stock (“Common Stock”), was below $1.00 per share for the prior 30 consecutive business days, the Company is not in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from March 3, 2026, or until August 31, 2026, to regain compliance with the Minimum Bid Price Requirement. If at any time before August 31, 2026, the closing bid price of the Company’s Common Stock closes at or above $1.00 per share for a minimum of 10 consecutive business days (which number of days may be extended by Nasdaq), Nasdaq will provide written notification that the Company has achieved compliance with the Minimum Bid Price Requirement, and the matter would be resolved. The Notice also disclosed that in the event the Company does not regain compliance with the Minimum Bid Price Requirement by August 31, 2026, the Company may be eligible for additional time. To qualify for additional time, the Company would be required to meet the applicable market value of publicly held shares requirement for continued listing and all other applicable standards for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and would need to provide written notice of its intention to cure the deficiency during the second compliance period. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting. The Company intends to continue actively monitoring the closing bid price for the Company’s Common Stock between now and August 31, 2026, and will consider available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement. In June 2025, our shareholders approved an amendment to our articles of incorporation to effect a reverse stock split at a ratio between 1-for-2 and 1-for-12. Our board of directors has authority to select an exchange ratio within the approved range at any time prior to June 3, 2026. The Company’s board of directors intends to effect the reverse stock split only if it determines the reverse stock split to be in the best interests of our shareholders. Such a reverse stock split would likely put us in compliance with the Minimum Bid Price Requirement. If the Company does not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel. There can be no assurance that the Company will regain compliance with the Minimum Bid Price Requirement during the 180-day compliance period, secure a second period of 180 calendar days to regain compliance, or maintain compliance with the other Nasdaq listing requirements. Announcement • Feb 28
Presurance Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $4.28464 million. Presurance Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $4.28464 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 4,284,640
Price\Range: $1
Discount Per Security: $0
Transaction Features: Rights Offering Announcement • Feb 13
James Petcoff Files Complaint Against Presurance Holdings, Inc and Clarkston 91 West On February 10, 2026, James Petcoff, a shareholder of Presurance Holdings, Inc. (the “Company”), filed a complaint against the Company, current and former directors of the Company, the Company’s Chief Executive Officer and Clarkston 91 West (“Clarkston 91”), which purchased preferred shares and warrants from the Company. The complaint alleges, among other things, breaches of fiduciary duties and Michigan law with respect to the sale by the Company of Series B Preferred Stock and Warrants to Clarkston 91 in February and March 2025 and the sale by the Company of Series C Preferred Stock to an affiliate of Clarkston 91 in December 2025. The Company is reviewing the complaint and intends to vigorously defend this matter. Announcement • Jan 15
Presurance Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $14 million. Presurance Holdings, Inc. has filed a Follow-on Equity Offering in the amount of $14 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 14,000,000
Price\Range: $1
Discount Per Security: $0
Transaction Features: Rights Offering Announcement • May 01
Conifer Holdings, Inc., Annual General Meeting, Jun 03, 2025 Conifer Holdings, Inc., Annual General Meeting, Jun 03, 2025. Announcement • Mar 05
Conifer Holdings, Inc. announced that it has received $2.5 million in funding from Clarkston Ventures, LLC Conifer Holdings, Inc entered into Securities Purchase Agreement with Clarkston 91 West LLC for private placement and issued 5,000 Series B Preferred Stock at an issue price of $500 on for gross proceeds of $2,500,000 on March 3, 2025. The preferred stock will mature on December 31, 2026. The preferred stock will carry a dividend rate of prime rate of Waterford Bank, N.A. (“Waterford Bank”) on the date that is 30 days prior to the applicable Dividend Payment Date plus 600 basis points. The outstanding Series B Preferred Shares shall only be redeemed by the Company at an amount per share equal to the Series B $500. Announcement • Sep 03
Conifer Holdings, Inc. Announces CEO Changes Conifer Holdings, Inc. announced that Mr. Nick Petcoff resigned as the Chief Executive Officer. The Board of Directors has appointed Brian Roney, Conifer’s President, to the position of Chief Executive Officer. Announcement • Aug 24
Conifer Holdings Receives Written Notice from Nasdaq Due to No Longer Complies with the Minimum Stockholders’ Equity Requirement Under Nasdaq Listing Rule 5550(b)(1) On August 16, 2024, Conifer Holdings Inc. (the ‘Company’) received written notice from the Nasdaq Stock Market LLC (‘Nasdaq’) stating that the Company no longer complies with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1) for continued listing on The Nasdaq Stock Market LLC because the Company’s stockholders’ equity, as reported in the Company’s Quarterly Report on Form 10-Q for the second quarter ended June 30, 2024, has fallen below $2.5 million. The notice also indicates that the Company does not meet the alternative compliance standards. Under applicable Nasdaq rules, the Company has 45 calendar days from the date of the notice, or until September 30, 2024, to submit a plan to regain compliance. The Company intends to timely submit such a plan to Nasdaq. If the Company’s plan is accepted, Nasdaq may grant the Company an extension of up to 180 calendar days from the date of the notice to evidence compliance. The notice has no immediate impact on the listing of the Company’s common stock, which will continue to trade on The Nasdaq Stock Market LLC under the symbol ‘CNFR’. Announcement • Aug 13
Conifer Holdings, Inc. to Report Q2, 2024 Results on Aug 13, 2024 Conifer Holdings, Inc. announced that they will report Q2, 2024 results After-Market on Aug 13, 2024 Announcement • May 09
Conifer Holdings, Inc. to Report Q1, 2024 Results on May 14, 2024 Conifer Holdings, Inc. announced that they will report Q1, 2024 results at 4:00 PM, US Eastern Standard Time on May 14, 2024 Announcement • Apr 28
Conifer Holdings, Inc., Annual General Meeting, May 22, 2024 Conifer Holdings, Inc., Annual General Meeting, May 22, 2024, at 10:00 US Eastern Standard Time. Agenda: To consider election of J. Grant Smith and Jeffrey Hakala for a three-year term expiring in 2027, or, in each case, until each of the earlier election and qualification of such director’s successor; to consider ratification of the appointment of Plante & Moran, PLLC as the Company’s independent registered public accounting firm; and to consider any other business that is properly submitted before the Annual Meeting or any adjournments or postponements thereof. Announcement • Apr 04
Conifer Holdings, Inc. to Report Q4, 2023 Results on Apr 04, 2024 Conifer Holdings, Inc. announced that they will report Q4, 2023 results After-Market on Apr 04, 2024 Announcement • Mar 25
Conifer Holdings Transfers Listing of Common Stock from Nasdaq Global to Nasdaq Capital As previously disclosed, on October 23, 2023, Conifer Holdings Inc. (the Company") received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market, LLC (the Nasdaq") notifying the Company that it was no longer in compliance with the requirement of a minimum Market Value of Publicly Held Shares (MVPHS") of $5,000,000 for continued listing on the Nasdaq Global Market, as set in Nasdaq Listing Rule 5450(b)(1)(C). As a result of the Approval (as defined below) of the transfer of the listing of the Company's common stock, no par value (the Common Stock") from the Nasdaq Global Market to the Nasdaq Capital Market, the Company has cured the MVPHS deficiency. On March 19, 2024, the Company received approval from Nasdaq to transfer the listing of the Company's Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market (the Approval"). The Company's Common Stock was transferred to the Nasdaq Capital Market effective as of the open of business on March 21, 2024, and continues to trade under the symbol CNFR." The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq's corporate governance requirements. The Company's 9.75% Senior Unsecured Notes due 2028 will continue to trade on the Nasdaq Global Market. Announcement • Jan 18
Conifer Holdings, Inc. Announces Board Appointments Conifer Holdings, Inc. announced that its Board of Directors has named Isolde G. O’Hanlon to the role of Acting Board Chair, effective immediately. Ms. O’Hanlon was elected to the Conifer Board of Directors in 2017. She has served as Chair of the Audit Committee since March 2019, and also serves as a member of the Compensation Committee and the Finance & Investment Committee. Ms. O’Hanlon has more than 25 years in the Insurance Investment Banking field. She has extensive experience in providing advice and capital raising to specialty property casualty carriers, insurance distribution firms and advising public pension funds and private equity on investments in the Insurance Industry. Ms. O’Hanlon graduated with an AB in Economics from Smith College. The Company also announced that J. Grant Smith has been elected to serve on the Company’s Board of Directors. With the addition of Mr. Smith, Conifer’s Board of Directors increases to ten members. Mr. Smith currently serves as the President and Chief Operating Officer for Waterford Bank, N.A. Mr. Smith executed the successful merger of Clarkston Financial Corporation and its wholly owned subsidiary Clarkston State Bank in January 2020 with Waterford Bancorp. During his first three years as President and CEO, Mr. Smith designed and implemented the turnaround plan for the Corporation, which ultimately resulted in the recapitalization of the Corporation and achieved record profitability and performance results post-recession. Mr. Smith received his B.B.A. in Finance and M.S. in Corporate Finance from Walsh College in Troy. Reported Earnings • Nov 15
Third quarter 2023 earnings released: US$0.22 loss per share (vs US$0.14 loss in 3Q 2022) Third quarter 2023 results: US$0.22 loss per share (further deteriorated from US$0.14 loss in 3Q 2022). Revenue: US$28.1m (up 6.8% from 3Q 2022). Net loss: US$2.71m (loss widened 78% from 3Q 2022). Revenue is expected to decline by 9.1% p.a. on average during the next 3 years, while revenues in the Insurance industry in the US are expected to grow by 6.4%. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings. New Risk • Nov 10
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: US$9.79m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Market cap is less than US$10m (US$9.79m market cap). Minor Risk Currently unprofitable and not forecast to become profitable next year (US$747k net loss next year). Announcement • Oct 29
Conifer Holdings Receives Notice from Nasdaq Regarding Non-Compliance with the Market Value of ‘Publicly Held’ Shares Rule On October 23, 2023, Conifer Holdings Inc. received a notice (the ‘Notice’) from The Nasdaq Stock Market LLC (‘Nasdaq’) indicating that for the past 30 consecutive business days prior to the date of the letter, the market value of ‘publicly held’ shares of the Company was less than $5.0 million, which does not meet the requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(C) (the ‘MVPHS Rule’). In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company has been provided a period of 180 calendar days, or until April 22, 2024, to regain compliance. To regain compliance with the MVPHS Rule, the market value of the Company’s publicly held shares must meet or exceed $5.0 million for a minimum of ten consecutive business days during the 180-day grace period. If the Company regains compliance with the MVPHS Rule by the expiration date of the compliance period, Nasdaq will provide written confirmation to the Company and close the matter. However, there can be no assurance that the Company will be able to regain compliance or that the Company will be able to maintain its Nasdaq listing. The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to trade on the Nasdaq Global Market under the symbol ‘CNFR’. The Company is presently evaluating possible courses of action to regain compliance with Nasdaq Listing Rule 5450(b)(1)(C). These options include, without limitation, the transfer of the Company’s common stock to the Nasdaq Capital Market in 2024. Announcement • Oct 28
Conifer Holdings, Inc. to Report Q3, 2023 Results on Nov 09, 2023 Conifer Holdings, Inc. announced that they will report Q3, 2023 results After-Market on Nov 09, 2023 Board Change • Sep 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 4 highly experienced directors. Independent Director Gerald W. Hakala was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Aug 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable next year (US$747k net loss next year). Share price has been volatile over the past 3 months (9.6% average weekly change). Market cap is less than US$100m (US$18.0m market cap). Price Target Changed • Aug 10
Price target decreased by 37% to US$1.07 Down from US$1.70, the current price target is provided by 1 analyst. New target price is 22% below last closing price of US$1.37. Stock is down 12% over the past year. The company is forecast to post a net loss per share of US$0.26 next year compared to a net loss per share of US$1.00 last year. New Risk • Aug 03
New minor risk - Profitability The company is currently unprofitable and not forecast to become profitable over the next year. Trailing 12-month net loss: US$6.8m Forecast net loss in 1 year: US$2.0m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-US$38m free cash flow). Minor Risks Currently unprofitable and not forecast to become profitable next year (US$2.0m net loss next year). Shareholders have been diluted in the past year (26% increase in shares outstanding). Market cap is less than US$100m (US$15.6m market cap). Reported Earnings • May 11
First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind First quarter 2023 results: EPS: US$0.082 (up from US$0.30 loss in 1Q 2022). Revenue: US$24.6m (down 3.1% from 1Q 2022). Net income: US$1.00m (up US$3.87m from 1Q 2022). Profit margin: 4.1% (up from net loss in 1Q 2022). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 2.2%. Earnings per share (EPS) exceeded analyst estimates. Revenue is forecast to grow 1.3% p.a. on average during the next 2 years, compared to a 5.9% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 18% per year. Reported Earnings • Mar 15
Full year 2022 earnings released: US$1.00 loss per share (vs US$0.11 loss in FY 2021) Full year 2022 results: US$1.00 loss per share (further deteriorated from US$0.11 loss in FY 2021). Revenue: US$104.9m (flat on FY 2021). Net loss: US$10.7m (loss widened US$9.59m from FY 2021). Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 15% per year, which means it is performing significantly worse than earnings. Announcement • Jan 18
Conifer Holdings, Inc. Announces Resignation of Andrew Petcoff from the Board of Directors Effective December 31, 2022, Andrew Petcoff resigned from the Board of Directors (the “Board”) of Conifer Holdings, Inc. (the "Company"). Mr. Petcoff's resignation was not the result of any dispute or disagreement with the Company or the Company’s Board on any matter relating to the operations, policies or practices of the Company. Price Target Changed • Jan 13
Price target increased to US$1.40 Up from US$1.25, the current price target is provided by 1 analyst. New target price is 14% below last closing price of US$1.62. Stock is down 33% over the past year. The company is forecast to post a net loss per share of US$1.08 next year compared to a net loss per share of US$0.11 last year. Recent Insider Transactions • Jan 06
Executive Chairman & Co-CEO recently sold US$300k worth of stock On the 30th of December, James Petcoff sold around 200k shares on-market at roughly US$1.50 per share. This transaction amounted to 5.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. James has been a net seller over the last 12 months, reducing personal holdings by US$295k. Major Estimate Revision • Nov 16
Consensus estimates of losses per share improve by 19% The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$100.5m to US$106.3m. EPS estimate increased from -US$1.33 per share to -US$1.07 per share. Insurance industry in the US expected to see average net income growth of 18% next year. Consensus price target down from US$1.35 to US$1.25. Share price fell 7.6% to US$1.34 over the past week. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 4 highly experienced directors. Independent Director Tim Lamothe was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 11
Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Third quarter 2022 results: US$0.14 loss per share (further deteriorated from US$0.13 loss in 3Q 2021). Revenue: US$26.3m (up 10.0% from 3Q 2021). Net loss: US$1.52m (loss widened 26% from 3Q 2021). Revenue exceeded analyst estimates by 11%. Earnings per share (EPS) missed analyst estimates by 7.7%. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Major Estimate Revision • Aug 18
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from US$96.6m to US$100.5m. Forecast EPS reduced from -US$0.70 to -US$1.33 per share. Insurance industry in the US expected to see average net income growth of 7.0% next year. Consensus price target down from US$2.00 to US$1.35. Share price rose 26% to US$1.96 over the past week. Reported Earnings • Aug 12
Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2022 results: US$0.86 loss per share (down from US$0.57 profit in 2Q 2021). Revenue: US$24.7m (down 7.0% from 2Q 2021). Net loss: US$8.40m (down 251% from profit in 2Q 2021). Revenue exceeded analyst estimates by 4.5%. Earnings per share (EPS) missed analyst estimates by 310%. Over the next year, revenue is forecast to grow 1.8%, compared to a 1.2% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jul 29
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$1.47, the stock trades at a trailing P/E ratio of 21.3x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 62% over the past three years. Price Target Changed • Jul 07
Price target decreased to US$2.00 Down from US$2.45, the current price target is an average from 3 analysts. New target price is 14% above last closing price of US$1.76. Stock is down 36% over the past year. The company is forecast to post a net loss per share of US$0.70 next year compared to a net loss per share of US$0.11 last year. Valuation Update With 7 Day Price Move • Jul 06
Investor sentiment improved over the past week After last week's 15% share price gain to US$1.76, the stock trades at a trailing P/E ratio of 25.4x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 53% over the past three years. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 19% share price gain to US$1.73, the stock trades at a trailing P/E ratio of 25x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 55% over the past three years. Board Change • Jun 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 4 highly experienced directors. Independent Director Tim Lamothe was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • May 25
Investor sentiment deteriorated over the past week After last week's 20% share price decline to US$1.38, the stock trades at a trailing P/E ratio of 20x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 65% over the past three years. Major Estimate Revision • May 19
Consensus revenue estimates fall by 13% The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$111.3m to US$96.6m. Forecast losses increased from -US$0.30 to -US$0.70 per share. Insurance industry in the US expected to see average net income decline 5.9% next year. Consensus price target of US$2.50 unchanged from last update. Share price fell 14% to US$1.73 over the past week. Reported Earnings • May 13
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: US$0.30 loss per share (up from US$0.48 loss in 1Q 2021). Revenue: US$25.4m (down 3.6% from 1Q 2021). Net loss: US$2.87m (loss narrowed 38% from 1Q 2021). Revenue missed analyst estimates by 4.4%. Earnings per share (EPS) also missed analyst estimates by 131%. Over the next year, revenue is forecast to grow 5.6% while the industry in the US is not expected to grow. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 09
Full year 2021 earnings: EPS misses analyst expectations Full year 2021 results: US$0.11 loss per share (down from US$0.062 profit in FY 2020). Revenue: US$104.3m (up 1.0% from FY 2020). Net loss: US$1.09m (down 284% from profit in FY 2020). Combined ratio: 112.9% (up from 108.4% in FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 17%. Over the next year, revenue is forecast to grow 4.4% compared to a 2.0% decline forecast for the insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 12
Third quarter 2021 earnings released: US$0.13 loss per share (vs US$0.056 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings and control over costs, although revenues were flat. Third quarter 2021 results: Revenue: US$26.7m (flat on 3Q 2020). Net loss: US$1.21m (down 324% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. Price Target Changed • Oct 09
Price target decreased to US$3.00 Down from US$3.50, the current price target is an average from 3 analysts. New target price is 15% above last closing price of US$2.62. Stock is down 6.1% over the past year. Recent Insider Transactions • Sep 30
Independent Director recently bought US$134k worth of stock On the 29th of September, Joseph Sarafa bought around 50k shares on-market at roughly US$2.68 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$196k more in shares than they have sold in the last 12 months. Valuation Update With 7 Day Price Move • Sep 13
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$3.17, the stock trades at a trailing P/E ratio of 6.5x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 44% over the past three years. Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment deteriorated over the past week After last week's 15% share price decline to US$2.66, the stock trades at a trailing P/E ratio of 5.4x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 59% over the past three years. Major Estimate Revision • Aug 18
Consensus revenue estimates increase to US$116.6m The consensus outlook for revenues in 2021 has improved. 2021 revenue forecast increased from US$104.9m to US$116.6m. Forecast losses expected to reduce from -US$0.80 to -US$0.06 per share. Insurance industry in the US expected to see average net income decline 9.3% next year. Consensus price target up from US$3.00 to US$3.50. Share price fell 2.8% to US$2.76 over the past week. Price Target Changed • Aug 13
Price target increased to US$3.50 Up from US$3.00, the current price target is an average from 3 analysts. New target price is 13% above last closing price of US$3.10. Stock is down 3.4% over the past year. Reported Earnings • Aug 12
Second quarter 2021 earnings released: EPS US$0.57 (vs US$0.16 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$35.5m (up 41% from 2Q 2020). Net income: US$5.55m (up 269% from 2Q 2020). Profit margin: 16% (up from 6.0% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • May 13
Investor sentiment deteriorated over the past week After last week's 17% share price decline to US$2.56, the stock trades at a trailing P/E ratio of 41.4x. Average forward P/E is 12x in the Insurance industry in the US. Total loss to shareholders of 56% over the past three years. Major Estimate Revision • May 13
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast increased from US$100.6m to US$103.7m. Forecast EPS reduced from -US$0.57 to -US$0.83 per share. Insurance industry in the US expected to see average net income decline 2.8% next year. Consensus price target down from US$3.60 to US$3.00. Share price fell 17% to US$2.56 over the past week. Major Estimate Revision • Apr 24
Consensus forecasts updated The consensus outlook for 2021 has been updated. 2021 revenue forecast increased from US$99.4m to US$100.6m. Forecast EPS reduced from -US$0.20 to -US$0.43 per share. Insurance industry in the US expected to see average net income growth of 5.3% next year. Consensus price target down from US$4.00 to US$3.60. Share price fell 8.6% to US$3.30 over the past week. Reported Earnings • Mar 14
Full year 2020 earnings released: EPS US$0.062 (vs US$0.88 loss in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$103.2m (up 7.5% from FY 2019). Net income: US$595.0k (up US$8.42m from FY 2019). Profit margin: 0.6% (up from net loss in FY 2019). Combined ratio: 108.4% (down from 110.8% in FY 2019). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Analyst Estimate Surprise Post Earnings • Mar 14
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 5.9%. Earnings per share (EPS) also surpassed analyst estimates. Over the next year, revenue is forecast to decline by -3.7% while the Insurance industry in the US is not expected to grow. Major Estimate Revision • Mar 03
Analysts lower EPS estimates to -US$0.20 The 2021 consensus revenue estimate was lowered from US$101.0m to US$99.4m. The company's losses are expected to worsen with analysts lowering their EPS forecasts from -US$0.017 to -US$0.20 for the same period. The Insurance industry in the US is expected to see an average net income growth of 7.9% next year. The consensus price target increased from US$2.50 to US$4.00. Share price stayed mostly flat at US$3.69 over the past week. Is New 90 Day High Low • Feb 25
New 90-day high: US$4.01 The company is up 78% from its price of US$2.25 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 9.0% over the same period. Reported Earnings • Feb 25
Full year 2020 earnings released: EPS US$0.062 (vs US$0.88 loss in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$103.5m (up 7.8% from FY 2019). Net income: US$595.0k (up US$8.42m from FY 2019). Profit margin: 0.6% (up from net loss in FY 2019). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Analyst Estimate Surprise Post Earnings • Feb 25
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 5.9%. Earnings per share (EPS) also surpassed analyst estimates. Over the next year, revenue is forecast to decline by -2.4% while the Insurance industry in the US is not expected to grow. Announcement • Feb 11
Conifer Holdings, Inc. to Report Q4, 2020 Results on Feb 23, 2021 Conifer Holdings, Inc. announced that they will report Q4, 2020 results After-Market on Feb 23, 2021 Is New 90 Day High Low • Feb 06
New 90-day high: US$3.97 The company is up 48% from its price of US$2.68 on 06 November 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 14% over the same period. Is New 90 Day High Low • Dec 31
New 90-day high: US$3.79 The company is up 32% from its price of US$2.88 on 30 September 2020. The American market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share. Is New 90 Day High Low • Nov 21
New 90-day low: US$2.39 The company is down 22% from its price of US$3.08 on 21 August 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is up 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share. Major Estimate Revision • Nov 21
Analysts increase EPS estimates to -US$0.31 The 2020 consensus revenue estimate increased from US$94.8m to US$97.8m. Analysts raised their EPS forecasts from -US$0.44 to -US$0.31 in 2020. The Insurance industry in the US is expected to see an average net income growth of 13% next year. The consensus price target of US$2.75 was unchanged from the last update. Share price is down by 11% to US$2.39 over the past week. Reported Earnings • Nov 18
Third quarter 2020 earnings released: EPS US$0.056 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$26.6m (up 11% from 3Q 2019). Net income: US$541.0k (up US$1.77m from 3Q 2019). Profit margin: 2.0% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Analyst Estimate Surprise Post Earnings • Nov 18
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) also surpassed analyst estimates. Over the next year, revenue is forecast to grow 1.9% while the growth in Insurance industry in the US is expected to stay flat. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS US$0.056 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$26.6m (up 11% from 3Q 2019). Net income: US$541.0k (up US$1.77m from 3Q 2019). Profit margin: 2.0% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 49% per year but the company’s share price has fallen by 24% per year, which means it is significantly lagging earnings. Analyst Estimate Surprise Post Earnings • Nov 14
Revenue and earnings beat expectations Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) also surpassed analyst estimates. Over the next year, revenue is forecast to grow 1.7% while the growth in Insurance industry in the US is expected to stay flat. Announcement • Oct 30
Conifer Holdings, Inc. to Report Q3, 2020 Results on Nov 11, 2020 Conifer Holdings, Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 11, 2020 Major Estimate Revision • Oct 23
Analysts update estimates The company's losses in 2020 are expected to worsen with analysts lowering their consensus EPS forecasts from -US$0.37 to -US$0.44. Revenue estimate was approximately flat at US$94.8m. The Insurance industry in the US is expected to see an average net income growth of 6.1% next year. The consensus price target of US$3.00 was unchanged from the last update. Share price is down by 3.4% to US$2.52 over the past week.